RxDoctor Payments DataLook up a doctor →

Emma Reeve

Medical · Scottsdale, AZNPI 1801374913

Payments from drug & device makers

$14,724in general payments, 2019–2025

Across 757 payments — averaging $19.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Novo Nordisk$1K
  • Corcept Therapeutics$1K
  • Lilly USA, LLC$1K
  • Abbott$949
  • Amgen$738
  • plus $6K from 42 others

What the payments were for

  • Travel & lodging$1,0157%
  • Food & beverage$13,58892%
  • Education$620%
  • Gifts$590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$14,724 in reported general payments places this provider in the 95th percentile of 748 medical providers in Arizona.

See all medical providers in Arizona

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide321$484,112
JardianceEmpagliflozin133$173,828
MounjaroTirzepatide123$151,502
TrulicityDulaglutide55$85,011
FarxigaDapagliflozin Propanediol72$68,670
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog53$50,763
Soliqua 100-33Insulin Glargine/Lixisenatide33$43,388
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog50$30,486
Tresiba Flextouch U-100Insulin Degludec46$29,917
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/731$29,526
Tresiba Flextouch U-200Insulin Degludec23$27,380
Synjardy XrEmpagliflozin/Metformin Hcl13$20,482
LyumjevInsulin Lispro-Aabc13$19,904
Lyumjev Kwikpen U-100Insulin Lispro-Aabc22$19,699
Humalog Kwikpen U-200Insulin Lispro15$18,163

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus, Novolog$1,479$502,733349 claims
Lilly USA, LLCMounjaro, Trulicity, Lyumjev, Humalog$1,444$263,406224 claims
Boehringer IngelheimJardiance, Synjardy Xr$254$194,310146 claims
AstraZenecaFarxiga$466$68,67072 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Lantus$610$45,71644 claims
AbbVieSynthroid$549$7,33177 claims
Cequr CorporationCequr Simplicity$87$4,70111 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium, Unithroid$188$3,899339 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 748 medical providers in Arizona.

Other medical in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →